| NDC Code | 0025-1901-31 |
|---|
| Package Description | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0025-1901-31) |
|---|
| Product NDC | 0025-1901 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Calan Sr |
|---|
| Non-Proprietary Name | Verapamil Hydrochloride |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 19910306 |
|---|
| End Marketing Date | 20220228 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA019152 |
|---|
| Manufacturer | Pfizer Laboratories Div Pfizer Inc |
|---|
| Substance Name | VERAPAMIL HYDROCHLORIDE |
|---|
| Strength | 120 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
|---|